Krsnaa Diagnostics Limited carries a market capitalization of 17.92B, placing it among publicly traded companies globally. Its enterprise value stands at 18.29B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 17.92B |
| Enterprise Value | 18.29B |
Krsnaa Diagnostics Limited currently has 32.44M shares outstanding.
| Shares Outstanding | 32.44M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Krsnaa Diagnostics Limited trades at a trailing price-to-earnings ratio of 16.63. The price-to-sales ratio is 2.18, and the price-to-book ratio stands at 104.02.
| PE Ratio | 16.63 |
| PS Ratio | 2.18 |
| PB Ratio | 104.02 |
| P/TBV Ratio | 1.73 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Krsnaa Diagnostics Limited trades at an EV/EBITDA multiple of 15.07 and an EV/FCF ratio of 68.42. The EV/Sales ratio of 2.37 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.07 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.37 |
| EV / EBITDA | 15.07 |
| EV / EBIT | 15.07 |
| EV / FCF | 68.42 |
Krsnaa Diagnostics Limited maintains a current ratio of 2.68, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 54.50, indicating elevated leverage, while an interest coverage ratio of 3.53 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 2.68 |
| Quick Ratio | 1.42 |
| Debt / Equity | 54.50 |
| Debt / EBITDA | 4.40 |
| Interest Coverage | 3.53 |
Krsnaa Diagnostics Limited posts a return on equity of 87.12 and a return on invested capital of 7.26.
| Return on Equity (ROE) | 87.12 |
| Return on Assets (ROA) | 6.53 |
| Return on Invested Capital (ROIC) | 7.26 |
| Return on Capital Employed (ROCE) | 26.41 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 8.58 |
Over the trailing twelve months, Krsnaa Diagnostics Limited has paid 289.38M in income taxes, reflecting an effective tax rate of 22.20.
| Income Tax | 289.38M |
| Effective Tax Rate | 22.20 |
Krsnaa Diagnostics Limited's stock has declined approximately -25.50676% over the past 52 weeks. The 50-day moving average sits at 559.28, while the 200-day moving average is 675.20.
| Beta (5Y) | N/A |
| 52-Week Price Change | -25.50676% |
| 50-Day Moving Average | 559.28 |
| 200-Day Moving Average | 675.20 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Krsnaa Diagnostics Limited generated 7.73B in revenue and converted that into 1.01B in net income, yielding earnings per share of 30.87. EBITDA reached 1.21B, while operating income came in at 1.21B.
| Revenue | 7.73B |
| Gross Profit | 5.32B |
| Operating Income | 1.21B |
| Pretax Income | 1.30B |
| Net Income | 1.01B |
| EBITDA | 1.21B |
| EBIT | 1.21B |
| Earnings Per Share (EPS) | 30.87 |
Krsnaa Diagnostics Limited holds 3.92B in cash and equivalents against 5.34B in total debt, resulting in a net debt position of 4.60B. Total book value stands at 162.19M, with working capital of 4.63B providing operational flexibility.
| Cash & Cash Equivalents | 3.92B |
| Total Debt | 5.34B |
| Net Debt | 4.60B |
| Equity (Book Value) | 162.19M |
| Book Value Per Share | 5.01 |
| Working Capital | 4.63B |
Krsnaa Diagnostics Limited operates with a gross margin of 68.85, reflecting its pricing power and cost economics. The operating margin of 15.71 and net profit margin of 13.13 provide insight into operational efficiency.
| Gross Margin | 68.85 |
| Operating Margin | 15.71 |
| Pretax Margin | 16.87 |
| Profit Margin | 13.13 |
| EBITDA Margin | 15.71 |
Krsnaa Diagnostics Limited posts an Altman Z-Score of 2.15, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.15 |